Cardinal Health (CAH) Tops Q4 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance
Cardinal Health (NYSE: CAH) reported Q4 EPS of $2.08, $0.05 better than the analyst estimate of $2.03. Revenue for the quarter came in at $60.2 billion versus the consensus estimate of $60.92 billion.
GUIDANCE:
Cardinal Health sees FY2026 EPS of $9.30-$9.50, versus the consensus of $9.25.
For earnings history and earnings-related data on Cardinal Health (CAH) click here.
